Physician was attempting to use an everflex entrust along with a 6fr sheath, 0.014" guidewire and 6.0 spider embolic protection during procedure to treat a severely calcified fibrous lesion in the proximal superficial femoral artery (sfa).The vessel was severely tortuous.The vessel diameter is 5/6mm.Abnormalities reported in relation to patient anatomy are tortuosity of iliac artery, bypass graft and chronic total occlusion (cto).There was no damage noted to packaging.There was no issue noted when removing the device from hoop/tray.The device was prepped per ifu with no issues identified.It was reported that stent deformation occurred in vivo during positioning or deployment.The physician completed the procedure with a 6.0 device.The lesion was predilated.The device did not pass through a previously deployed stent.There was resistance encountered when advancing the device, unknown if excessive force was used.There was patient complications associated with this event, partial stent was left in the artery which was surgically removed.Physician went to or to retrieve portion of stent left in patient's common femoral artery.Physician took another entrust and stented the lesion.There was patient injury reported with common femoral open endart and partial stent removal.
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|